High-flux hemodialysis and hemodiafiltration - Impact on outcome

Contributions to Nephrology

Volumn 137, Issue , 2002, Pages 193-200

  Locatelli, Francesco ^a   Pozzoni, Pietro ^a   Manzoni, Celestina ^a   Di Filippo, Salvatore ^a  

^a A MANZONI HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN;

ANEMIA; ARTICLE; CARDIOVASCULAR FUNCTION; HEMODIAFILTRATION; HUMAN; ISOLATION AND PURIFICATION; METHODOLOGY; MORBIDITY; MORTALITY; NUTRITION; RENAL REPLACEMENT THERAPY; TREATMENT OUTCOME;

ANEMIA; BETA 2-MICROGLOBULIN; CARDIOVASCULAR PHYSIOLOGY; HEMODIAFILTRATION; HUMANS; MORBIDITY; NUTRITION PHYSIOLOGY; RENAL DIALYSIS; TREATMENT OUTCOME;

EID: 0036053973     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (12)

1. Locatelli F, Andrulli S, Pecchini F, Pedrini L, Agliata S, Lucchi L, Farina M, La Milia V, Grassi C, Borghi M, Redaelli B, Conte F, Ratto G, Cabiddu G, Grossi C, Modenese R: Effect of high-flux dialysis on the anaemia of haemodialysis patients. Nephrol Dial Transplant 2000;15:1399-1409.
2. Wizemann V, Lotz C, Techert F, Uthoff S: On-line hemodiafiltration versus low-flux haemodialysis: A prospective randomized study. Nephrol Dial Transplant 2000;15:43-48.
3. Locatelli F, Mastrangelo F, Redaelli B, Ronco C, Marcelli D, La Greca G, Orlandini G: Effects of different membranes and dialysis technologies on patient treatment tolerance and nutritional parameters. Kidney Int 1996;50:1293-1302.
4. Schiffl H, Fisher R, Lang SM, Mangel E: Clinical manifestations of AB-amyloidosis: Effects of biocompatibility and flux. Nephrol Dial Transplant 2000;16:840-845.
5. Nakai S, Iseki K, Tabei K, Kubo K, Masakane I, Fushimi K, Kikuchi K, Shinzato T, Sanaka T, Akiba T: Outcomes of hemodiafiltration based on japanese dialysis patient registry. Am J Kidney Dis 2001;(suppl 38):212-216.
6. Locatelli F, Manzoni C: Treatment modalities in comparison: When do clinical differences emerge? Nephrol Dial Transplant 2000;(suppl 15):29-35.
7. Koda Y, Nishi S, Miyazaki S, Haginoshita S, Sakurabayashi T, Suzuki M, Sakai S, Yuasa Y, Hirasawa Y, Nishi T: Switch from conventional to high-flux membrane reduces the risk of carpal tunnel syndrome and mortality of hemodialysis patients. Kidney Int 1997;52:1096-1101.
8. Leypoldt JK, Cheung AK, Carrol CE, et al: Effect of dialysis membranes and middle molecule removal on chronic hemodialysis patient survival. Am J Kidney Dis 1999;33:349-355.
9. Locatelli F, Marcelli D, Conte F, Limido A, Malberti A, Spotti D for the Registro Lombardo Dialisi e Trapianto: Comparison of mortality in ESRD patients on convective and diffusive extracorporeal treatments. Kidney Int 1999;55:286-293.
10. Port FK, Wolfe RA, Hulbert-Shearon TE, Daugirdas JT, Agodoa LY, Jones C, Orzol SM, Held PJ: Mortality risk by hemodialyzer reuse practice and dialyzer membrane characteristics: results from the USRDS dialysis morbidity and mortality study. Am J Kidney Dis 2001;37:276-286.
11. Eknoyan G, Levey AS, Beck GJ, Agodoa LY, Daugirdas JT, Kusek JW, Levin NW, Schulman G: The Haemodialysis (HEMO) Study: Rationale for selection of interventions. Semin Dial 1996;9:24-33.
12. Locatelli F, Hannedouche T, Jacobson S, La Greca G, Loureiro A, Martin-Malo A, Papadimitriou M, Vanholder R: The effect of membrane permeability on ESRD: Design of prospective randomised multicentre trial. J Nephrol 1999;12:85-88.